Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['lenalidomide', ' lena', 'cartitude4', 'mmsm', 'multiplemyeloma', 'cartitude', 'ciltacabtagene autoleucel']
 new #asco23 study summary for patients: in #multiplemyeloma #cartitude4 study, ciltacabtagene autoleucel reduces risk of disease progression better than standard therapy after lenalidomide #cartcells #mmsm
Timely, trusted, compassionate doctor-approved info from @ASCO. Signup https://t.co/2KibiNRMFU

We can't answer individual medical questions.

Retweet ≠Endorsement